127 related articles for article (PubMed ID: 33250680)
1. Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas.
Sajed R; Saeednejad Zanjani L; Rahimi M; Mansoori M; Zarnani AH; Madjd Z; Ghods R
EXCLI J; 2020; 19():1423-1435. PubMed ID: 33250680
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
3. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.
Raja SA; Shah STA; Tariq A; Bibi N; Sughra K; Yousuf A; Khawaja A; Nawaz M; Mehmood A; Khan MJ; Hussain A
Oncol Lett; 2019 Jul; 18(1):219-226. PubMed ID: 31289491
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.
Zhang J; Yang F; Ding Y; Zhen L; Han X; Jiao F; Tang J
Int J Clin Exp Pathol; 2015; 8(8):9240-7. PubMed ID: 26464672
[TBL] [Abstract][Full Text] [Related]
7. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Expression of Prolactin Receptor and TGFβ Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome.
Hachim IY; López-Ozuna VM; Hachim MY; Lebrun JJ; Ali S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987013
[TBL] [Abstract][Full Text] [Related]
9. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
Burkhardt M; Mayordomo E; Winzer KJ; Fritzsche F; Gansukh T; Pahl S; Weichert W; Denkert C; Guski H; Dietel M; Kristiansen G
J Clin Pathol; 2006 Apr; 59(4):403-9. PubMed ID: 16484444
[TBL] [Abstract][Full Text] [Related]
11. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
[TBL] [Abstract][Full Text] [Related]
12. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.
Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM
Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090
[TBL] [Abstract][Full Text] [Related]
13. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
15. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
Kleer CG; Griffith KA; Sabel MS; Gallagher G; van Golen KL; Wu ZF; Merajver SD
Breast Cancer Res Treat; 2005 Sep; 93(2):101-10. PubMed ID: 16187229
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
Kurozumi S; Alsaeed S; Orah N; Miligy IM; Joseph C; Aljohani A; Toss MS; Fujii T; Shirabe K; Green AR; Aleskandarany MA; Rakha EA
Breast Cancer Res Treat; 2020 Feb; 179(3):557-564. PubMed ID: 31707510
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
Shafiei S; Kalantari E; Saeednejad Zanjani L; Abolhasani M; Asadi Lari MH; Madjd Z
Exp Mol Pathol; 2019 Jun; 108():164-172. PubMed ID: 31028726
[TBL] [Abstract][Full Text] [Related]
19. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
20. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
